Emmaus Life Sciences Accelerates Middle East and North Africa (MENA) Growth Strategy with Opening of its Dubai Office

TORRANCE, Calif., July 23, 2020 (GLOBE NEWSWIRE) — Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, announced today the opening of its regional office in Dubai. The Dubai office will be utilized to enhance Emmaus’ relationships with clinicians and patient groups at major hospitals and other government-sponsored health care facilities in communities throughout the Middle East and North Africa (MENA) region. These partnerships are intended to accelerate Emmaus’ path to registration and commercialization of Endari® and to ensure that the estimated 100,000 potentially treatable sickle cell disease patients in the MENA region have access to the product information and real-time assistance needed to effectively treat their disease.